AzTrials
AzTrials

AnxietyLISTNCT02279251

School Based Low-intensity Cognitive Behavioral Intervention for Anxious Youth

A study testing VÅG and CHILLED in people with Anxiety, run by NORCE Norwegian Research Centre AS at 3 sites in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study will evaluate two group CBT interventions delivered by school health nurses, in cooperation with community psychologist and mental health care personnel, to adolescents with mild to moderate levels of anxiety symptoms. The two interventions have different intensity (5 versus 10 group meetings). Read more about this study

Who is it for?
Ages 12 to 16 years
Conditions the study is for
Anxiety
What is being tested?
VÅG and CHILLED
Could I receive a placebo?
No, everyone receives an active treatment
How many people
313 participants
Where
3 sitesNorway
Study dates
Oct 2013to 1 Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • An overall score of > 25 on the anxiety inventory Spence Children's Anxiety Scale (SCAS) and a score of > 1 on the first question of the Children's Anxiety Life Interference Scale (CALIS), indicating that anxiety interferes with daily life of the youth, rated either by the adolescents or by one parent.
  • The adolescent and at least one parent understand and read Norwegian.
  • Assent from the youth and signed informed consent from the parent.

Who cannot join

  • The adolescent has a behavior that makes participation in groups with other adolescents challenging. This is evaluated by the school nurse, based on information from the adolescent, the parent and the teacher. In each case, the school nurse makes an evaluation based on the following questions:
  • Is the adolescent able to follow group-rules?
  • Will the adolescent behave in ways that disrupts the group?
  • Does the adolescent have learning problems to an extent that will make it difficult to follow the group program?

Trial locations and contacts

3 sites in 1 country.

Norway3 sites
  • Municipality of Fjell, Sund and Askoy

    Fjell

  • Sorlandet Hospital HF

    Kristiansand

  • Municipality of Modum

    Oslo, East Norway

Other trials in Norway

About this study

Official title: School Based Low-intensity Cognitive Behavioral Intervention for Anxious Youth. A Randomized Controlled Trial

The study will evaluate two group CBT interventions delivered by school health nurses, in cooperation with community psychologist and mental health care personnel, to adolescents with mild to moderate levels of anxiety symptoms. The two interventions have different intensity (5 versus 10 group meetings). The two group interventions will be compared to a waitlist control group.

Read the detailed description

Anxiety disorders are among the major mental health problems in children and adolescents, with regard to prevalence and long-term consequences. Cognitive behavioural therapy (CBT) has proven to be effective as treatment, early intervention and prevention of youth anxiety disorders. The majority of youth with anxiety problems, however, is not in contact with mental health services and do not receive effective help. This is due to shortage of personnel, resources and time among mental health-personal delivering treatment, as well as health services not being easily accessable for adolescents. School-based, low-intensity early intervention programs (indicated prevention) may improve access to effective treatment for youth with internalizing problems, and also promote more effective use of health services. The present study is a multi-site randomized controlled study with early intervention to be conducted within the primary health care service in three parts of Norway; including nine municipalities from west, east and south of Norway. A brief CBT program will be compared to a longer CBT program, and a wait-list control group. The effects will be evaluated with regard to decrease in youth internalizing symptoms. The CBT interventions are given to adolescents with mild to moderate levels of anxiety symptoms. Interventions are delivered by trained school-health nurses in collaboration with and/or supervised by experienced CBT therapists. The study involves researchers from three research environments in Norway, and collaboration with prominent international researchers from USA and Australia.The study has potential impact on how to deliver effective low-threshold interventions to anxious youth.

Conditions
Anxiety
Being tested
VÅG, CHILLED
Keywords
Anxiety, adolescents, school-based, low-intensity CBT
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VÅGBehavioural

    Low-intensity CBT intervention

  • CHILLEDBehavioural

    Standard length CBT intervention

Study groups in NCT02279251
Study groupRoleWhat they receive
Brief CBT (VÅG)Active comparatorThis is a brief five session CBT group intervention developed at Uni Research. The intervention include self-help material (Psychological First Aid) for the adolescents to use at home between sessions.
Receives: Behavioral: VÅG
Established CBT program (Cool Kids)Active comparatorAn established, 10 session CBT group program (school version) developed by researchers at Macquarie University, Australia. The intervention has previously not been evaluated with Norwegian adolescents.
Receives: Behavioral: CHILLED
WaitlistNo interventionWaiting period is ten weeks, then participants are randomized to one of the two active interventions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Spence Children's Anxiety Scale

    Self-reported (child and parent version) child anxiety symptoms, 38 items questionnaire, rated at a 4-point scale.

    Measured: Changes from baseline to 4 weeks, 10 weeks, and 1 year

  2. Children Anxiety Life Interference Scale

    Self-reported (child and parent version) of degree of life interference of child anxiety symptoms

    Measured: Changes from baseline to 4 weeks,10 weeks, and 1 year

Secondary outcomes (4)
  1. Short Mood and Feeling Questionnaire

    Questionnaire measuring symptoms of depression (child and parent version)

    Measured: Changes from baseline to 4 weeks,10 weeks,and 1 year

  2. Questionnaire for Measuring Health-Related Quality of Life Children and Adolescents (KINDL-R)

    Questionnaire (child and parents version) measuring quality of life in youth

    Measured: Changes from baseline to 10 weeks, and 1 year

  3. Clinical Global Impression Scale, severity/improvement (CGI-S/I)

    The clinician's (i.e. the school health nurse) global assessment of level of youth anxiety

    Measured: Changes from baseline to 10 weeks, and 1 year

  4. Sleep problems

    Questionnaire (youth) on variables related to sleep (sleep duration, insomnia etc.)

    Measured: Changes from baseline, up to 10 weeks, and after 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2014 (estimated)
  2. Study startOct 2013
  3. Primary completionJul 2018
  4. Study completion1 Nov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
313 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02279251
Sponsor's protocol ID
229020
Acronym
LIST
Status last verified
Aug 2021
First submitted
15 Oct 2014
Last updated
18 Aug 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Haugland BSM, Haaland AT, Baste V, Bjaastad JF, Hoffart A, Rapee RM, Raknes S, Himle JA, Husabo E, Wergeland GJ. Effectiveness of Brief and Standard School-Based Cognitive-Behavioral Interventions for Adolescents With Anxiety: A Randomized Noninferiority Study. J Am Acad Child Adolesc Psychiatry. 2020 Apr;59(4):552-564.e2. doi: 10.1016/j.jaac.2019.12.003. Epub 2020 Jan 8.

    PubMed 31926224
  • Haugland BS, Raknes S, Haaland AT, Wergeland GJ, Bjaastad JF, Baste V, Himle J, Rapee R, Hoffart A. School-based cognitive behavioral interventions for anxious youth: study protocol for a randomized controlled trial. Trials. 2017 Mar 4;18(1):100. doi: 10.1186/s13063-017-1831-9.

    PubMed 28259171
  • Haugland BSM, Hysing M, Baste V, Wergeland GJ, Rapee RM, Hoffart A, Haaland AT, Bjaastad JF. Sleep Duration and Insomnia in Adolescents Seeking Treatment for Anxiety in Primary Health Care. Front Psychol. 2021 Mar 24;12:638879. doi: 10.3389/fpsyg.2021.638879. eCollection 2021.

    PubMed 33841272
  • Haugland BSM, Hysing M, Hoffart A, Haaland AT, Bjaastad JF, Wergeland GJ, Baste V. Effect of early intervention for anxiety on sleep outcomes in adolescents: a randomized trial. Eur Child Adolesc Psychiatry. 2022 Oct;31(10):1-15. doi: 10.1007/s00787-021-01795-6. Epub 2021 May 7.

    PubMed 33961115

Questions about this trial

What is this clinical trial studying?

A study testing VÅG and CHILLED in people with Anxiety, run by NORCE Norwegian Research Centre AS at 3 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Spence Children's Anxiety Scale (time frame: Changes from baseline to 4 weeks, 10 weeks, and 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02279251, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in